Clinical utility of fulvestrant in the treatment of breast cancer: a report on the emerging clinical evidence

por Rocca, Andrea, Maltoni, Roberta, Bravaccini, Sara, Donati, Caterina, Andreis, Daniele
Publicado 2018

Expression of genes involved in DNA repair and cell cycle checkpoint pathways in Triple Negative compared to Luminal A Breast Cancer: a molecular characterization

por Ganzinelli, Monica, Ribeiro, Enilze, Bertoni, Ramona, Bazzola, Letizia, Andreis, Daniele, Bottini, Alberto, Giardini, Roberto, Rossi, Camillo, Damia, Giovanna, Generali, Daniele
Publicado 2012

Evaluation of Androgen Receptor in Relation to Estrogen Receptor (AR/ER) and Progesterone Receptor (AR/PgR): A New Must in Breast Cancer?

por Bronte, Giuseppe, Rocca, Andrea, Ravaioli, Sara, Scarpi, Emanuela, Bonafè, Massimiliano, Puccetti, Maurizio, Maltoni, Roberta, Andreis, Daniele, Martinelli, Giovanni, Bravaccini, Sara
Publicado 2019

Optimisation and validation of a remote monitoring system (Onco-TreC) for home-based management of oral anticancer therapies: an Italian multicentre feasibility study

por Passardi, Alessandro, Rizzo, Mimma, Maines, Francesca, Tondini, Carlo, Zambelli, Alberto, Vespignani, Roberto, Andreis, Daniele, Massa, Ilaria, Dianti, Marco, Forti, Stefano, Piras, Enrico Maria, Eccher, Claudio
Publicado 2017

Triple Negative Breast Cancers Have a Reduced Expression of DNA Repair Genes

por Ribeiro, Enilze, Ganzinelli, Monica, Andreis, Daniele, Bertoni, Ramona, Giardini, Roberto, Fox, Stephen B., Broggini, Massimo, Bottini, Alberto, Zanoni, Vanessa, Bazzola, Letizia, Foroni, Chiara, Generali, Daniele, Damia, Giovanna
Publicado 2013

A Remote Monitoring System to Optimize the Home Management of Oral Anticancer Therapies (ONCO-TreC): Prospective Training–Validation Trial

por Passardi, Alessandro, Foca, Flavia, Caffo, Orazio, Tondini, Carlo Alberto, Zambelli, Alberto, Vespignani, Roberto, Bartolini, Giulia, Sullo, Francesco Giulio, Andreis, Daniele, Dianti, Marco, Eccher, Claudio, Piras, Enrico Maria, Forti, Stefano
Publicado 2022

Phase Ib dose-finding trial of lapatinib plus pegylated liposomal doxorubicin in advanced HER2-positive breast cancer

por Rocca, Andrea, Cecconetto, Lorenzo, Passardi, Alessandro, Melegari, Elisabetta, Andreis, Daniele, Monti, Manuela, Maltoni, Roberta, Sarti, Samanta, Pietri, Elisabetta, Schirone, Alessio, Fabbri, Francesco, Donati, Caterina, Nanni, Oriana, Fedeli, Anna, Faedi, Marina, Amadori, Dino
Publicado 2017

Androgen Receptor Expression in Breast Cancer: What Differences Between Primary Tumor and Metastases?

por Bronte, Giuseppe, Bravaccini, Sara, Ravaioli, Sara, Puccetti, Maurizio, Scarpi, Emanuela, Andreis, Daniele, Tumedei, Maria Maddalena, Sarti, Samanta, Cecconetto, Lorenzo, Pietri, Elisabetta, De Simone, Valeria, Maltoni, Roberta, Bonafè, Massimiliano, Amadori, Dino, Rocca, Andrea
Publicado 2018

Nuclear HER4 mediates acquired resistance to trastuzumab and is associated with poor outcome in HER2 positive breast cancer

por Nafi, Siti Norasikin Mohd, Generali, Daniele, Kramer-Marek, Gabriela, Gijsen, Merel, Strina, Carla, Cappelletti, Mariarosa, Andreis, Daniele, Haider, Syed, Li, Ji-Liang, Bridges, Esther, Capala, Jacek, Ioannis, Roxanis, Harris, Adrian L, Kong, Anthony
Publicado 2014

Androgen receptor in advanced breast cancer: is it useful to predict the efficacy of anti-estrogen therapy?

por Bronte, Giuseppe, Rocca, Andrea, Ravaioli, Sara, Puccetti, Maurizio, Tumedei, Maria Maddalena, Scarpi, Emanuela, Andreis, Daniele, Maltoni, Roberta, Sarti, Samanta, Cecconetto, Lorenzo, Fedeli, Anna, Pietri, Elisabetta, De Simone, Valeria, Asioli, Silvia, Amadori, Dino, Bravaccini, Sara
Publicado 2018

ADAM10 mediates trastuzumab resistance and is correlated with survival in HER2 positive breast cancer

por Feldinger, Katharina, Generali, Daniele, Kramer-Marek, Gabriela, Gijsen, Merel, Ng, Tzi Bun, Wong, Jack Ho, Strina, Carla, Cappelletti, Mariarosa, Andreis, Daniele, Li, Ji-Liang, Bridges, Esther, Turley, Helen, Leek, Russell, Roxanis, Ioannis, Capala, Jacek, Murphy, Gillian, Harris, Adrian L., Kong, Anthony
Publicado 2014

Phase II Study of Dehydroepiandrosterone in Androgen Receptor‐Positive Metastatic Breast Cancer

por Pietri, Elisabetta, Massa, Ilaria, Bravaccini, Sara, Ravaioli, Sara, Tumedei, Maria Maddalena, Petracci, Elisabetta, Donati, Caterina, Schirone, Alessio, Piacentini, Federico, Gianni, Lorenzo, Nicolini, Mario, Campadelli, Enrico, Gennari, Alessandra, Saba, Alessandro, Campi, Beatrice, Valmorri, Linda, Andreis, Daniele, Fabbri, Francesco, Amadori, Dino, Rocca, Andrea
Publicado 2018

Phase II study of liposomal doxorubicin, docetaxel and trastuzumab in combination with metformin as neoadjuvant therapy for HER2-positive breast cancer

por Rocca, Andrea, Cortesi, Pietro, Cortesi, Laura, Gianni, Lorenzo, Matteucci, Federica, Fantini, Lorenzo, Maestri, Antonio, Giunchi, Donata Casadei, Cavanna, Luigi, Ciani, Rosa, Falcini, Fabio, Bagni, Antonella, Meldoli, Elena, Dall’Agata, Monia, Volpi, Roberta, Andreis, Daniele, Nanni, Oriana, Curcio, Annalisa, Lucchi, Leonardo, Amadori, Dino, Fedeli, Anna
Publicado 2021